NBT Technology

ANCON Medical has developed a revolutionary technology called Nanoparticle Biomarker Tagging that gives medical professionals the capability to detect deadly diseases in a patient’s breath.

Disease Screening

No matter the disease, early diagnosis gives medical personnel more opportunities for treatment. NBT technology offers powerful capabilities to screen for a wide range of diseases with unprecedented sensitivity.

Medical Alley

As a member of Medical Alley, the community of health industry leaders, ANCON Medical is committed to being a leader in the research and development of innovative healthcare technology.

Biomarker Detection

Research has demonstrated that early detection in the medical field can save lives; letting patients start treatment before the disease spreads beyond control. Highly sensitive breath biomarker detection through our NBT technology offers a non-invasive, point-of-care solution for diagnosticians and enables them to offer life-saving treatment at earlier stages before diseases can progress.



Focusing on the development of revolutionary, non-invasive disease screening technology, ANCON Medical Inc. is a medical device maker focusing on the development of revolutionary, non-invasive disease screening technology.

News and Articles

ANCON Medical presents unique solutions for the healthcare industry, providing a pathway to early detection capabilities that can be critical for treating deadly illnesses like lung cancer, tuberculosis and others. Read latest news and articles related to healthcare industry.

Latest News & Articles

Read all articles
May 9, 2020

Innovation To Tackle Regional Covid Hotspots

Wesley Baker, CEO of ANCON Medical discusses screening and utilising technology to protect our most densely populated areas in the future.

Contact Us

  • UK –  01227 811705
  • USA – Please use contact form

NBT Technology Video